Home > Riviste > Minerva Gastroenterologica e Dietologica > Fascicoli precedenti > Minerva Gastroenterologica e Dietologica 2018 June;64(2) > Minerva Gastroenterologica e Dietologica 2018 June;64(2):147-57

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

Rivista di Gastroenterologia, Nutrizione e Dietetica


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEW  LIVER TRANSPLANTATION: INDICATIONS AND OUTCOMES


Minerva Gastroenterologica e Dietologica 2018 June;64(2):147-57

DOI: 10.23736/S1121-421X.17.02453-9

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Hepatitis B and liver transplantation

Alberto FERRARESE, Alberto ZANETTO, Francesco P. RUSSO

Multivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy


PDF  


Liver transplantation (LT) is the only effective treatment for hepatitis B-virus (HBV) related end stage liver disease, even if the outcome of these patients, has significantly improved after introduction of effective and well tolerated nucleoside/nucleotide analogues (NUC). Pre-transplant therapy has been initially based on lamivudine, but entecavir and tenofovir represent the currently recommended first-line therapeutic option in patients with HBV decompensated cirrhosis. After LT, the development of hepatitis B immunoglobulin (HBIG) in the early 1990’s dramatically changes the prognosis of these patients by reducing the incidence of HBV recurrence and increasing survival rate. Combination of HBIG and NUC is now considered as the standard of care for prophylaxis against HBV recurrence, however personalized therapeutic algorithms based on pre- and post-transplant viral and host factors have been proposed. Finally, liver grafts from hepatitis B core antibody-positive donors and from hepatitis B antigen-positive donors can be safely used in selected patients.


KEY WORDS: Hepatitis B virus - Liver transplantation - Acute-on-chronic liver failure - Hepatocellular carcinoma - Antiviral agents

inizio pagina

Publication History

Issue published online: March 30, 2018
Article first published online: November 10, 2017
Manuscript accepted: November 7, 2017
Manuscript received: November 1, 2017

Per citare questo articolo

Ferrarese A, Zanetto A, Russo FP. Hepatitis B and liver transplantation. Minerva Gastroenterol Dietol 2018;64:147-57. DOI: 10.23736/S1121-421X.17.02453-9

Corresponding author e-mail

francescopaolo.russo@unipd.it